Aurobindo Pharma has informed that it enclosed copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities, a wholly owned subsidiary of the Company, for Pemetrexed for Injection.
The above information is a part of company’s filings submitted to BSE.